Synergistic Anti-Tumor Effect of Simvastatin Combined to Chemotherapy in Osteosarcoma

par Adèle Mangelinck, Nadia Habel, Audrey Mohr, Nathalie Gaspar, Bojana Stefanovska, Olivia Fromigué
Publié 2021

MT2A is an early predictive biomarker of response to chemotherapy and a potential therapeutic target in osteosarcoma

par Adèle Mangelinck, Maria Eugénia Marques da Costa, Bojana Stefanovska, Olivia Bawa, Mélanie Polrot, Nathalie Gaspar, Olivia Fromigué
Publié 2019

Histone Variant H2A.J Is Enriched in Luminal Epithelial Gland Cells

par Christophe E. Redon, Zoe Schmal, Gargi Tewary, Adèle Mangelinck, Régis Courbeyrette, Jean-Yves Thuret, Mirit I. Aladjem, William M. Bonner, Claudia E. Rübe, Carl Mann
Publié 2021